serw-MX  [xml]  

 DeCS Categories

D08 Enzymes and Coenzymes .
D08.811 Enzymes .
D08.811.913 Transferases .
D08.811.913.696 Phosphotransferases .
D08.811.913.696.620 Phosphotransferases (Alcohol Group Acceptor) .
D08.811.913.696.620.682 Protein Kinases .
D08.811.913.696.620.682.725 Protein-Tyrosine Kinases .
D08.811.913.696.620.682.725.400 Receptor Protein-Tyrosine Kinases .
D08.811.913.696.620.682.725.400.075 Proto-Oncogene Proteins c-met .
D12 Amino Acids, Peptides, and Proteins .
D12.776 Proteins .
D12.776.543 Membrane Proteins .
D12.776.543.750 Receptors, Cell Surface .
D12.776.543.750.630 Receptor Protein-Tyrosine Kinases .
D12.776.543.750.630.186 Proto-Oncogene Proteins c-met .
D12.776.543.750.705 Receptors, Immunologic .
D12.776.543.750.705.816 Receptors, Antigen .
D12.776.543.750.705.833 Receptors, Complement .
D12.776.543.750.705.833.600 Receptors, Complement 3b .
D12.776.543.750.705.833.610 Receptors, Complement 3d .
D12.776.543.750.705.871 Receptors, Fc .
D12.776.543.750.750 Receptors, Peptide .
D12.776.543.750.750.400 Receptors, Growth Factor .
D12.776.543.750.750.400.100 Proto-Oncogene Proteins c-met .
D12.776.543.750.830 Receptors, Virus .
D12.776.543.750.830.250 Receptors, Complement 3d .
D12.776.624 Neoplasm Proteins .
D12.776.624.664 Oncogene Proteins .
D12.776.624.664.700 Proto-Oncogene Proteins .
D12.776.624.664.700.186 Proto-Oncogene Proteins c-met .
D12.776.826 Receptors, Cytoplasmic and Nuclear .
D12.776.826.750 Receptors, Steroid .
D12.776.826.750.765 Receptors, Progesterone .
G12 Immune System Phenomena .
G12.100 Antibody Specificity .
H02 Health Occupations .
H02.403 Medicine .
H02.403.220 Community Medicine .
SP8 Disasters .
SP8.473 Risk 17142 .
SP8.473.654 Hazards .
SP8.473.654.412 Technological Threats .
SP8.473.654.412.057 Hazardous Substances, Products and Materials .
SP8.473.654.412.057.089 Pollutants .
 Synonyms & Historicals
Receptors, Complement 3b .
CD 35 Antigens .
CD35 Antigen .
Complement 3b Receptor .
Antigen, CD35 .
Antigens, CD 35 .
Receptor, Complement 3b .
Antigens, CD35 .
Complement 3b Receptors .
CD35 Antigens .
CR1 Receptors .
C3b Receptors .
Receptors, CR1 .
Receptors, C3b .
Molecular sites on or in some B-lymphocytes and macrophages that recognize and combine with COMPLEMENT C3B. The primary structure of these receptors reveal that they contain transmembrane and cytoplasmic domains, with their extracellular portion composed entirely of thirty short consensus repeats each having 60 to 70 amino acids. .
Receptors, Complement .
Complement Receptor .
Complement Receptor Type 1 .
Receptor, Complement .
Complement Receptors .
Molecules on the surface of some B-lymphocytes and macrophages, that recognize and combine with the C3b, C3d, C1q, and C4b components of complement. .
Receptors, Fc .
Fc Receptor .
Receptor, Fc .
Fc Receptors .
Molecules found on the surface of some, but not all, B-lymphocytes, T-lymphocytes, and macrophages, which recognize and combine with the Fc (crystallizable) portion of immunoglobulin molecules. .
Receptors, Antigen .
Antigen Receptor .
Receptor, Antigen .
Antigen Receptors .
Molecules on the surface of B- and T-lymphocytes that recognize and combine with specific antigens. .
Community Medicine .
Medicine, Community .
A branch of medicine concerned with the total health of the individual within the home environment and in the community, and with the application of comprehensive care to the prevention and treatment of illness in the entire community. .
Antibody Specificity .
Antibody Specificities .
Specificities, Antibody .
Specificity, Antibody .
The property of antibodies which enables them to react with some ANTIGENIC DETERMINANTS and not with others. Specificity is dependent on chemical composition, physical forces, and molecular structure at the binding site. .
Receptors, Progesterone .
Progesterone Receptor .
Receptor, Progesterone .
Progesterone Receptors .
Progestin Receptors .
Receptors, Progestin .
Specific proteins found in or on cells of progesterone target tissues that specifically combine with progesterone. The cytosol progesterone-receptor complex then associates with the nucleic acids to initiate protein synthesis. There are two kinds of progesterone receptors, A and B. Both are induced by estrogen and have short half-lives. .
Pollutants .
Contaminants .
Every compound of chemical or biological origin that on contact with air, with water, soil or with food, changes and affects the balance of its normal composition. .
Receptors, Complement 3d .
CD 21 Antigens .
CD21 Antigen .
Complement 3d Receptor .
Complement Receptor 2 .
Epstein-Barr Virus Receptor .
Herpesvirus 4 Receptors, Human .
Receptors, Epstein-Barr Virus .
Antigen, CD21 .
Antigens, CD 21 .
Epstein Barr Virus Receptor .
Epstein Barr Virus Receptors .
Receptor 2, Complement .
Receptor, Complement 3d .
Receptor, Epstein-Barr Virus .
Receptors 2, Complement .
Receptors, Epstein Barr Virus .
Virus Receptor, Epstein-Barr .
Virus Receptors, Epstein-Barr .
Antigens, CD21 .
Complement 3d Receptors .
CD21 Antigens .
CR2 Receptors .
C3d Receptors .
Receptors, CR2 .
Receptors, C3d .
Complement Receptors 2 .
Epstein-Barr Virus Receptors .
Molecular sites on or in B-lymphocytes, follicular dendritic cells, lymphoid cells, and epithelial cells that recognize and combine with COMPLEMENT C3D. Human complement receptor 2 (CR2) serves as a receptor for both C3dg and the gp350/220 glycoprotein of HERPESVIRUS 4, HUMAN, and binds the monoclonal antibody OKB7, which blocks binding of both ligands to the receptor. .
Proto-Oncogene Proteins c-met .
MET Proto-Oncogene, Receptor Tyrosine Kinase .
MET Receptor Tyrosine Kinase .
Receptor, HGF .
Receptor, Hepatocyte Growth Factor .
Receptor, Scatter Factor .
Scatter Factor Receptor .
c-Met Receptor Tyrosine Kinase .
MET Proto Oncogene, Receptor Tyrosine Kinase .
Proto Oncogene Proteins c met .
Proto-Oncogene Proteins, met .
c Met Receptor Tyrosine Kinase .
c met Proteins .
met Proto Oncogene Proteins .
HGF Receptor .
Hepatocyte Growth Factor Receptor .
c-met Proteins .
met Proto-Oncogene Proteins .
Proto-Oncogene Protein c-met .
Cell surface protein-tyrosine kinase receptors for HEPATOCYTE GROWTH FACTOR. They consist of an extracellular alpha chain which is disulfide-linked to the transmembrane beta chain. The cytoplasmic portion contains the catalytic domain and sites critical for the regulation of kinase activity. Mutations in the c-met proto-oncogene are associated with papillary renal carcinoma and other neoplasia. .